Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 460-464

  Zubach, Vanessa ^a   Smart, Gerry ^b   Ratnam, Samuel ^a,c   Severini, Alberto ^a,d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CADHAM PROVINCIAL LABORATORY   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; VIRUS DNA;

ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; CROSS HYBRIDIZATION; DNA HYBRIDIZATION; GENE AMPLIFICATION; GENOTYPE; MOLECULAR CLONING; MOLECULAR PROBE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CLINICAL LABORATORY TECHNIQUES; DNA, VIRAL; GENOTYPE; HUMANS; MICROSPHERES; MOLECULAR TYPING; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 84856200289     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06090-11     Document Type: Article

References (24)

1. Andall-Brereton GM, et al. 2011. Human papilloma virus prevalence in a sample of women in the Caribbean island of Trinidad. Rev. Panam. Salud Publica 29:2220-2226.
2. Bosch FX, et al. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl. 10):K1-K16.
3. Bouvard V, et al. 2009. A review of human carcinogens. Part B: biological agents. Lancet Oncol. 10:321-322.
4. Coutlee F, et al. 2007. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J. Clin. Microbiol. 45:3821-3823. (Pubitemid 350156895)
5. Coutlee F, et al. 2006. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J. Clin. Microbiol. 44:1998-2006. (Pubitemid 43902145)
6. Cuzick J, et al. 2008. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26(Suppl. 10):K29-K41.
7. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057-1062.
8. D'Souza G, et al. 2007. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356:1944-1956. (Pubitemid 46740304)
9. Eklund C, Zhou T, Dillner J. 2010. Global proficiency study of human papillomavirus genotyping. J. Clin. Microbiol. 48:4147-4155.
10. Giuliano AR, et al. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26(Suppl. 10):K17-K28.
11. Gravitt PE, et al. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361. (Pubitemid 30043317)
12. Harper DM, et al. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757-1765. (Pubitemid 39488060)
13. Jiang HL, Zhu HH, Zhou LF, Chen F, Chen Z. 2006. Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J. Med. Microbiol. 55:715-720. (Pubitemid 43855659)
14. Kerr C, Sadowski PD. 1972. Gene 6 exonuclease of bacteriophage T7. II. Mechanism of the reaction. J. Biol. Chem. 247:311-318.
15. Khan MJ, et al. 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 97:1072-1079. (Pubitemid 41417924)
16. Munoz N, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527. (Pubitemid 36159887)
17. Nikiforov TT, Rendle RB, Kotewicz ML, Rogers YH. 1994. The use of phosphorothioate primers and exonuclease hydrolysis for the preparation of single-stranded PCR products and their detection by solid-phase hybridization. PCR Methods Appl. 3:285-291.
18. Oh Y, et al. 2007. Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types. Cancer Sci. 98:549-554. (Pubitemid 46562746)
19. Poljak M, Kocjan BJ. 2010. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev. Anti Infect. Ther. 8:1139-1162.
20. Schmitt M, et al. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512. (Pubitemid 43222244)
21. Seme K, et al. 2009. Digene HPV genotyping RH test RUO: comparative evaluation with INNO-LiPAHPVgenotyping extra test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes. J. Clin. Virol. 46:176-179.
22. Villa LL, et al. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6:271-278. (Pubitemid 40590263)
23. Wallace J, Woda BA, Pihan G. 2005. Facile, comprehensive, highthroughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J. Mol. Diagn. 7:72-80. (Pubitemid 40310168)
24. Zehbe I, et al. 2011. Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study. BMJ Open 1(1):e000030. doi: 10.1136/bmjopen-2010-000030.